Trial Profile
Human Recombinant Endostatin Injection Durative Transfusion Combined With Chemotherapy in The First-line Treatment of Advanced Lung Squamous Carcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Lung cancer; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 17 Jan 2017 New trial record